16 September 2016 (Friday) - Anticoagulation
Here’s an interesting article. It investigates how various medical specialists coordinate anticoagulation bridging decisions for certain patients with atrial fibrillation.
Long-term anticoagulant therapy is essential for stroke prevention among patients with atrial fibrillation, but increasing evidence also points to substantial risk for adverse events, especially when anticoagulation is even only temporarily interrupted.
A recently published Effectiveness of Bridging Anticoagulation for Surgery Trial confirmed prior observational evidence that using short-acting anticoagulants periprocedurally increases bleeding risk without any reduction in stroke risk.
Little is known about how medical specialists coordinate the complex decision of which patients to bridge…
Labels: journal review